Warfarin therapy: how the less interesting half just got interesting.
Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
G P
GP
Miller
D000082:Acetaminophen / Q000009:adverse effects / Q000627:therapeutic use; D000925:Anticoagulants / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*; D017963:Azithromycin / Q000009:adverse effects / Q000627:therapeutic use; D002927:Cimetidine / Q000009:adverse effects / Q000627:therapeutic use; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004347:Drug Interactions; D000077156:Gefitinib; D006801:Humans; D009853:Omeprazole / Q000009:adverse effects / Q000627:therapeutic use; D011799:Quinazolines / Q000009:adverse effects / Q000627:therapeutic use; D013237:Stereoisomerism; D013379:Substrate Specificity; D014859:Warfarin / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*
D000925:Anticoagulants; D011799:Quinazolines; D000082:Acetaminophen; D014859:Warfarin; D002927:Cimetidine; D017963:Azithromycin; D003577:Cytochrome P-450 Enzyme System; D009853:Omeprazole; D000077156:Gefitinib